Validated germline-competent embryonic stem cell lines from nonobese diabetic mice

Nature Medicine

Volumn 15, Issue 7, 2009, Pages 814-818

  Nichols, Jennifer ^a   Jones, Kenneth ^a   Phillips, Jenny M ^a   Newland, Stephen A ^a   Roode, Mila ^a   Mansfield, William ^a   Smith, Austin ^a   Cooke, Anne ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LINE; CHIMERA; CONTROLLED STUDY; DNA MODIFICATION; EMBRYO; EMBRYONIC STEM CELL; FEMALE; GENE LOCUS; GERM LINE; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL; VALIDATION PROCESS;

ANIMALS; CELL LINE; CHIMERA; DIABETES MELLITUS, TYPE 1; EMBRYONIC STEM CELLS; FEMALE; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED NOD;

MUS;

EID: 67650432118     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.1996     Document Type: Article

References (19)

1. Redondo, M.J., Fain, P.R. & Eisenbarth, G.S. Genetics of type 1A diabetes. Recent Prog. Horm. Res. 56, 69-89 (2001).
2. Kikutani, H. & Makino, S. The murine autoimmune diabetes model: NOD and related strains. Adv. Immunol. 51, 285-322 (1992).
3. Wicker, L.S., Todd, J.A. & Peterson, L.B. Genetic control of autoimmune diabetes in the NOD mouse. Annu. Rev. Immunol. 13, 179-200 (1995).
4. Serreze, D.V. & Leiter, E.H. Genes and cellular requirements for autoimmune diabetes susceptibility in nonobese diabetic mice. Curr. Dir. Autoimmun. 4, 31-67 (2001).
5. Brook, F.A. et al. The derivation of highly germline-competent embryonic stem cells containing NOD-derived genome. Diabetes 52, 205-208 (2003).
6. Nagafuchi, S. et al. Establishment of an embryonic stem (ES) cell line derived from a non-obese diabetic (NOD) mouse: in vivo differentiation into lymphocytes and potential for germ line transmission. FEBS Lett. 455, 101-104 (1999).
7. Yang, W. et al. Pluripotin combined with LIF greatly promotes the derivation of ES cell lines from refractory strains. Stem Cells 27, 383-389 (2009).
8. Arai, S., Minjares, C., Nagafuchi, S. & Miyazaki, T. Improved experimental procedures for achieving efficient germ line transmission of nonobese diabetic (NOD)-derived embryonic stem cells. Exp. Diabesity Res. 5, 219-226 (2004).
9. Ying, Q.L. et al. The ground state of embryonic stem cell self-renewal. Nature 453, 519-523 (2008).
10. Buehr, M. et al. Capture of authentic embryonic stem cells from rat blastocysts. Cell 135, 1287-1298 (2008).
11. Silva, J. & Smith, A. Capturing pluripotency. Cell 132, 532-536 (2008).
12. Li, P. et al. Germ line competent embryonic stem cells derived from rat blastocysts. Cell 135, 1299-1310 (2008).
13. Solter, D. & Knowles, B.B. Immunosurgery of mouse blastocyst. Proc. Natl. Acad. Sci. USA 72, 5099-5102 (1975).
14. McClive, P.J. & Sinclair, A.H. Rapid DNA extraction and PCR-sexing of mouse embryos. Mol. Reprod. Dev. 60, 225-226 (2001).
15. Bradley, A., Evans, M., Kaufman, M.H. & Robertson, E. Formation of germ-line chimae-ras from embryo-derived teratocarcinoma cell lines. Nature 309, 255-256 (1984).
16. + regulatory T cells. J. Immunol 177, 6603-6612 (2006).
17. Guo, G. et al. Klf4 reverts developmentaly programmed restriction of ground state pluripotency. Development 136, 1063-1069 (2009).
18. Wang, W. et al. Chromosomal transposition of PiggyBac in mouse embryonic stem cells. Proc. Natl. Acad. Sci. USA 105, 9290-9295 (2008).
19. Ying, Q.L., Stavridis, M., Griffiths, D., Li, M. & Smith, A. Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture. Nat. Biotechnol. 21, 183-186 (2003).